CAPR News

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Capricor Therapeutics, Inc. (CAPR) And Encourages Stockholders to Reach Out

Lowey Dannenberg, P.C. is Investigating Capricor Therapeutics, Inc. (NASDAQ: CAPR) for Potential Violations of the Federal Securities Laws

CAPR SHAREHOLDER INVESTIGATION: Levi & Korsinsky Investigates Capricor Therapeutics, Inc. for Possible Securities Law Violations

CAPR SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Capricor

Capricor Therapeutics, Inc. Investigation Initiated: Levi & Korsinsky Investigates the Officers and Directors of Capricor Therapeutics, Inc. (CAPR)

Capricor Therapeutics Provides Update on FDA Advisory Committee Meeting for Deramiocel

CAPR Investor Alert: Capricor Therapeutics Investors Encouraged to Contact Kehoe Law Firm, P.C. Regarding Securities Investigation

Levi & Korsinsky Announces Investigation of Securities Claims Against Capricor Therapeutics, Inc. (CAPR)

Capricor Therapeutics, Inc. Investigation Initiated: Levi & Korsinsky Investigates the Officers and Directors of Capricor Therapeutics, Inc. (CAPR)

Rosen Law Firm Encourages Capricor Therapeutics Inc. Investors to Inquire About Securities Class Action Investigation - CAPR